Shivani Srivastava, PhD
DownloadHi-Res Photo
About
Titles
Postdoctoral Associate
Appointments
Pathology
Postdoctoral AssociatePrimary
Other Departments & Organizations
Education & Training
- Postdoctoral Scholar
- David Geffen School of Medicine, UCLA, USA
- Postdoctoral Scholar
- Wexner Medical Center, OSU, USA
- PhD
- (Biochemistry), Institute of Medical Sciences, BHU, India (availed UGC Fellowship)
- Guest Faculty
- B.Voc. in Medical Lab Technology, BHU, India
- Senior Research Fellow
- IIVR, Indian Council of Agricultural Research, India
- MSc
- (Biochemistry), Institute of Science, BHU, India
- BSc (Hon)
- (Botany, Zoology, Chemistry), BHU, India
Research
Overview
Medical Subject Headings (MeSH)
Aging; Bone Diseases; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Obesity
Research at a Glance
Yale Co-Authors
Frequent collaborators of Shivani Srivastava's published research.
Publications Timeline
A big-picture view of Shivani Srivastava's research output by year.
Demetrios Braddock, MD, PhD
Fotios Koumpouras, MD
Joao Pereira, PhD
Paul Stabach
19Publications
Publications
Expression kinetics reveal the self-adaptive role of β cells during the progression of diabetes.
Srivastava S, Pandey H, Tripathi YB. Expression kinetics reveal the self-adaptive role of β cells during the progression of diabetes. Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie 2018, 106: 472-482. PMID: 29990835, DOI: 10.1016/j.biopha.2018.06.168.Peer-Reviewed Original ResearchIncretin hormones receptor signaling plays the key role in antidiabetic potential of PTY-2 against STZ-induced pancreatitis.
Srivastava S, Shree P, Pandey H, Tripathi YB. Incretin hormones receptor signaling plays the key role in antidiabetic potential of PTY-2 against STZ-induced pancreatitis. Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie 2018, 97: 330-338. PMID: 29091882, DOI: 10.1016/j.biopha.2017.10.071.Peer-Reviewed Original ResearchGLP 1 Regulated Intestinal Cell's Insulin Expression and Selfadaptation before the Onset of Type 2 Diabetes.
Srivastava S, Pandey H, Singh SK, Tripathi YB. GLP 1 Regulated Intestinal Cell's Insulin Expression and Selfadaptation before the Onset of Type 2 Diabetes. Advanced Pharmaceutical Bulletin 2019, 9: 325-330. PMID: 31380261, PMCID: PMC6664108, DOI: 10.15171/apb.2019.039.Peer-Reviewed Original ResearchAnti-oxidant, anti-apoptotic, anti-hypoxic and anti-inflammatory conditions induced by PTY-2 against STZ-induced stress in islets.
Srivastava S, Pandey H, Singh SK, Tripathi YB. Anti-oxidant, anti-apoptotic, anti-hypoxic and anti-inflammatory conditions induced by PTY-2 against STZ-induced stress in islets. Bioscience Trends 2019, 13: 382-393. PMID: 31597821, DOI: 10.5582/bst.2019.01181.Peer-Reviewed Original ResearchActive phytochemicals of Pueraria tuberosa for DPP-IV inhibition: in silico and experimental approach.
Srivastava S, Shree P, Tripathi YB. Active phytochemicals of Pueraria tuberosa for DPP-IV inhibition: in silico and experimental approach. Journal Of Diabetes And Metabolic Disorders 2017, 16: 46. PMID: 29201861, PMCID: PMC5697100, DOI: 10.1186/s40200-017-0328-0.Peer-Reviewed Original ResearchPueraria tuberosa as Dipeptidyl-Peptidase-IV Inhibitor Prevents Streptozotocin-Induced Intestinal Stress.
Srivastava S, Pandey H, Singh SK, Tripathi YB. Pueraria tuberosa as dipeptidyl-peptidase-IV inhibitor prevents streptozotocin-induced intestinal stress. Open Access Macedonian Journal of Medical Sciences. 2021;9(A):28-34.Peer-Reviewed Original ResearchEpigenetic Regulation of Gut Microbial Dysbiosis.
Srivastava S, Singh A, Sandeep K, Yadav D. Epigenetic Regulation of Gut Microbial Dysbiosis. Indian Journal Of Microbiology 2021, 1-5. PMID: 33612870, PMCID: PMC7877904, DOI: 10.1007/s12088-021-00920-y.Peer-Reviewed Original ResearchImmune Modulatory Effects of Ketogenic Diet in Different Disease Conditions
Srivastava, S*, Pawar, V.A*, Tyagi, A*, Sharma, K.P*, Kumar, V.; Shukla, S.K. Immune Modulatory Effects of Ketogenic Diet in Different Disease Conditions. Immuno 2023, 3, 1-15. https://doi.org/10.3390/immuno3010001Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsEfficacy of Bioactive Compounds in the Regulation of Metabolism and Pathophysiology in Cardiovascular Diseases
Pawar VA*, Srivastava S*, Tyagi A*, Tayal R*, Shukla SK, Kumar V. Efficacy of Bioactive Compounds in the Regulation of Metabolism and Pathophysiology in Cardiovascular Diseases. Curr Cardiol Rep 2023 PMID: 37458865, DOI: 10.1007/s11886-023-01917-3.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsGut Microbiome and the Metabolic Syndrome
Srivastava S, Aditi P, Yadav D. Gut Microbiome and Metabolic Syndrome. The Metabolic Syndrome: Dietary Supplements and Food Ingredients. 2023.Chapters
Academic Achievements and Community Involvement
activity Reviewer
Journal ServiceBMC Complementary Medicine and Therapies, Diabetology & Metabolic Syndrome, Frontiers in Endocrinology, Frontiers in Immunology, Frontiers in Pharmacology, International Journal of Data Mining and Bioinformatics, Journal of Diabetes Research, Journal of Obesity, Molecular Biology Reports, Oncology Research, PLOS ONE, Scientific report.Details2022 - Presentactivity Guest Editor
Journal ServiceFrontiers in Aging (TOPIC: Premature Aging, its Consequences, and Targeted Therapy)Details2024 - Present